Literature DB >> 10453584

Clinical experience in acupuncture treatment of obesity.

J Li1.   

Abstract

Obesity manifests itself as derangement of qi and blood with disorder of the defensive qi in particular to be a causative factor of primary importance, meanwhile, deficiency of the primary qi in Sanjiao may also contribute to it. Fundamentally, its pathological changes are also related to dysfunction of the spleen and stomach. According to syndrome differentiation, obesity can be classified into three types, namely, heat in the stomach and intestine, spleen and stomach qi deficiency, and deficiency of primary qi. The main methods of treatment include clearing and reducing heat in the stomach and intestine; regulating qi in the fu organs and promoting water metabolism; balancing and regulating qi and blood, yin and yang, and removing stagnation of defensive qi.

Entities:  

Mesh:

Year:  1999        PMID: 10453584

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Effect of Laser Acupuncture on Anthropometric Measurements and Appetite Sensations in Obese Subjects.

Authors:  Chi-Chuan Tseng; Alan Tseng; Jason Tseng; Chia-Hao Chang
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-09       Impact factor: 2.629

2.  The Relationships between Leptin, Genotype, and Chinese Medicine Body Constitution for Obesity.

Authors:  Hsiang-I Hou; Hsing-Yu Chen; Jang-Jih Lu; Shih-Cheng Chang; Hsueh-Yu Li; Kun-Hao Jiang; Jiun-Liang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-07       Impact factor: 2.629

3.  Transcutaneous electrical stimulation of acupoints changes body composition and heart rate variability in postmenopausal women with obesity.

Authors:  Li-Wei Chien; Miao-Hsiang Lin; Hsueh-Yu Chung; Chi-Feng Liu
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-20       Impact factor: 2.629

4.  Association of TCM body constitution with insulin resistance and risk of diabetes in impaired glucose regulation patients.

Authors:  Hong You; Tong Zhang; Wen Feng; Yun Gai
Journal:  BMC Complement Altern Med       Date:  2017-09-11       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.